Professor | Jianying Huang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Jianying Huang
Contact Information	znyylcsy@126.com
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Jianying Huang

Contact Information

znyylcsy@126.com

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	Over 30 years of experience in clinical evaluation of new drugs Currently serves at the Clinical Trial Center of Zhongnan Hospital of Wuhan University (National Drug Clinical Trial Institution)
Work Experience	Executive Deputy Director, Office Director, Clinical Trial Center, Zhongnan Hospital, Wuhan University
Awards	National Model Worker (2021.03) Advanced Worker in the Provincial Association for Science and Technology System (2022.08) One of Hubei's Top 100 Outstanding Women in Science and Technology Innovation (2020.09) Advanced Individual in Wuhan's Fight Against COVID-19 Epidemic (2020) Second Prize, Hubei Province Science and Technology Progress Award for 'Combined Clinical Research Platform Establishment and Technological Innovation Application' (2022)

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

Over 30 years of experience in clinical evaluation of new drugs
Currently serves at the Clinical Trial Center of Zhongnan Hospital of Wuhan University (National Drug Clinical Trial Institution)

Work Experience

Executive Deputy Director, Office Director, Clinical Trial Center, Zhongnan Hospital, Wuhan University

Awards

National Model Worker (2021.03)
Advanced Worker in the Provincial Association for Science and Technology System (2022.08)
One of Hubei's Top 100 Outstanding Women in Science and Technology Innovation (2020.09)
Advanced Individual in Wuhan's Fight Against COVID-19 Epidemic (2020)
Second Prize, Hubei Province Science and Technology Progress Award for 'Combined Clinical Research Platform Establishment and Technological Innovation Application' (2022)

Areas of Focus	Clinical evaluation of drugs and medical devices Medical science and technology achievement transformation research
Publications	Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial, Shipo Wu, Jianying Huang, et al., 2021 Multifunctional MOF-Based Microneedle Patch With Synergistic Chemo-Photodynamic Antibacterial Effect and Sustained Release of Growth Factor for Chronic Wound Healing, Zeng YN, Wang CY, Lei K, Xiao C, Jiang X, Zhang W, Wu LJ, Huang JY, Li W, 2023 Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study, Feng Ying, Huang Jianying, Wu Jianyuan, Xu Yan, Chen Bo, Jiang Lijun, Xiang Hui, Peng Zhiyong, Wang Xinghuan, 2020 Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects, Yixin Hu, Jianyuan Wu, Xin Jiang, Guiying Chen, Yang Zhang, Luqin Si, Hongliang Jiang, Jiangeng Huang, Jianying Huang, 2022 Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial, Chen Chang, Zhang Yi, Huang Jianying, Yin Ping, Cheng Zhenshun, Wu Jianyuan, Chen Song, Zhang Yongxi, Chen Bo, Lu Mengxin, Ju Lingao, Zhang Jingyi, Wang Xinghuan, 2021 Effect of SHR0302 on the Pharmacokinetics of CYP3A4, CYP2C8, CYP2C9, and CYP2C19 Probe Substrates in Healthy Volunteers: A Cocktail Analysis, Fu M, Luo L, Feng S, Lin H, Lu Z, Gu F, Fan Y, Wu B, Huang J, Shen K, 2023

Areas of Focus

Clinical evaluation of drugs and medical devices
Medical science and technology achievement transformation research

Publications

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial, Shipo Wu, Jianying Huang, et al., 2021
Multifunctional MOF-Based Microneedle Patch With Synergistic Chemo-Photodynamic Antibacterial Effect and Sustained Release of Growth Factor for Chronic Wound Healing, Zeng YN, Wang CY, Lei K, Xiao C, Jiang X, Zhang W, Wu LJ, Huang JY, Li W, 2023
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study, Feng Ying, Huang Jianying, Wu Jianyuan, Xu Yan, Chen Bo, Jiang Lijun, Xiang Hui, Peng Zhiyong, Wang Xinghuan, 2020
Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects, Yixin Hu, Jianyuan Wu, Xin Jiang, Guiying Chen, Yang Zhang, Luqin Si, Hongliang Jiang, Jiangeng Huang, Jianying Huang, 2022
Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial, Chen Chang, Zhang Yi, Huang Jianying, Yin Ping, Cheng Zhenshun, Wu Jianyuan, Chen Song, Zhang Yongxi, Chen Bo, Lu Mengxin, Ju Lingao, Zhang Jingyi, Wang Xinghuan, 2021
Effect of SHR0302 on the Pharmacokinetics of CYP3A4, CYP2C8, CYP2C9, and CYP2C19 Probe Substrates in Healthy Volunteers: A Cocktail Analysis, Fu M, Luo L, Feng S, Lin H, Lu Z, Gu F, Fan Y, Wu B, Huang J, Shen K, 2023

Clinical Trials Drug Evaluation Medical Devices Research Transformation Technology Medical Science Innovation Regulatory Compliance Gcp

Ye Qifa - Wuhan University

Zhou Xin - Wuhan University

Bin Ren - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us